Carbenoxolone does not cross the blood brain barrier: an HPLC study

BACKGROUND: Carbenoxolone (CBX) is a widely used gap junctional blocker. Considering several reports indicating that transient gap junctional blockade could be a favourable intervention following injuries to central nervous tissue, and some current enthusiasm in studies using systemic injections of...

Descripción completa

Detalles Bibliográficos
Autores principales: Leshchenko, Yevgen, Likhodii, Sergei, Yue, Wendy, Burnham, William M, Perez Velazquez, Jose L
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351195/
https://www.ncbi.nlm.nih.gov/pubmed/16405728
http://dx.doi.org/10.1186/1471-2202-7-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1351195/
https://www.ncbi.nlm.nih.gov/pubmed/16405728
http://dx.doi.org/10.1186/1471-2202-7-3

Ejemplares similares